ClinicalTrials.Veeva

Menu

Effect of High Carbohydrate vs. Low Carbohydrate Diet in Type 2 Diabetes

The University of Alabama at Birmingham logo

The University of Alabama at Birmingham

Status

Completed

Conditions

Diabetes Mellitus
Diabetes Mellitus, Type 2

Treatments

Other: No Glycogen Loading
Other: glycogen loading

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT04416204
R01DK029953 (U.S. NIH Grant/Contract)
22074

Details and patient eligibility

About

The experimental approach in this study intends to investigate the role of hepatic glycogen content on nocturnal regulation of endogenous glucose production including the relative contributions of glycogenolysis and gluconeogenesis and the extent to which this differs between subjects with type 2 diabetes and subjects without diabetes. Both participants with type 2 diabetes and participants without diabetes will be studied after consuming either a low carbohydrate (no glycogen loading) or high carbohydrate (glycogen loading) diet.

Full description

Physiology study for looking at glycogen loading vs non loading in improving nightime glucose tolerance by increasing glycogen in liver and resulting higher glycogenolysis at night.

Enrollment

34 patients

Sex

All

Ages

30 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 30-75

  • BMI 20-35kg/m^2

  • Participants with type 2 diabetes:

    • HbA1c less than or equal to 8.5% on lifestyle therapy or monotherapy with metformin or sulphonylureas (SU); or less than or equal to 7.5% on two oral hypoglycemic agents (Metformin and SU)

Exclusion criteria

  • Pregnancy or breast feeding

  • Morbidities precluding participation

  • Participants with type 2 diabetes:

    • Therapy with insulin
    • SGLT2 inhibitors
    • GLP-1 based approaches
    • TZDs
    • Unstable diabetic retinopathy
    • Microalbuminuria
    • Macrovascular disease
    • Medications affecting GI motility (eg., erythromycin, pramlintide)
    • Upper GI disorder/surgery
  • Participants without diabetes:

    • Medications (except stable thyroid hormone or hormone replacement therapy) that could influence glucose tolerance
    • History of diabetes mellitus in first degree family members or prior history of diabetes mellitus or gestational diabetes, or pre-diabetes

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

34 participants in 2 patient groups

Type 2 diabetes
Experimental group
Description:
Participants with Type 2 Diabetes received Glycogen loading (GL) and Non-Glycogen loading (NGL) meal in a randomized manner.
Treatment:
Other: glycogen loading
Other: No Glycogen Loading
Participants without diabetes
Experimental group
Description:
Participants with no Diabetes received Glycogen loading (GL) and Non-Glycogen loading (NGL) meal in a randomized manner.
Treatment:
Other: glycogen loading
Other: No Glycogen Loading

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems